What do systematic reviews say?

RBD‐specific polyclonal F(ab') 2 fragments of equine antibodies (EpAbs) vs saline placebo

The review found no eligible studies for this question.

• Hyperimmune immunoglobulin for people with COVID‐19 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Hyperimmune immunoglobulin from human plasma vs saline placebo

The review found no eligible studies for this question.

• Hyperimmune immunoglobulin for people with COVID‐19 2023 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Music therapy vs placebo or usual care

• Music therapy for autistic people 2022 · Cochrane Headline outcomes only
  no estimate extracted
  3 studies · 340 participants
  Moderate

Dextromethorphan and quinidine sulfate combination (DMQ) vs placebo

The review found no eligible studies for this question.

• Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Scopolamine (hyoscine) patches vs placebo

The review found no eligible studies for this question.

• Treatment for sialorrhea (excessive saliva) in people with motor neuron disease/amyotrophic lateral sclerosis 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Add‐on felbamate vs placebo

• Felbamate add‐on therapy for drug‐resistant focal epilepsy 2022 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 64 participants
  Very low

Rituximab vs placebo

• Rituximab for thyroid‐associated ophthalmopathy 2022 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 25 participants
  Very low

Stiripentol vs add‐on placebo

The review found no eligible studies for this question.

• Stiripentol add‐on therapy for drug‐resistant focal epilepsy 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Summary of findings table ‐ Adjunctive therapies in addition to land‐based exercise therapy vs placebo adjunctive therapies

• Adjunctive therapies in addition to land‐based exercise therapy for osteoarthritis of the hip or knee 2022 · Cochrane Headline outcomes only
  no estimate extracted
  2 studies · 82 participants
  Moderate

Dexrazoxane vs no cardioprotective intervention or placebo

The review found no eligible studies for this question.

• Dexrazoxane for preventing or reducing cardiotoxicity in adults and children with cancer receiving anthracyclines 2022 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Antipsychotics vs placebo

The review found no eligible studies for this question.

• Pharmacological treatment for psychotic depression 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Antidepressant plus antipsychotic vs placebo

The review found no eligible studies for this question.

• Pharmacological treatment for psychotic depression 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Antidepressant plus antipsychotic vs placebo/no adjunctive treatment + antipsychotics

The review found no eligible studies for this question.

• Pharmacological treatment for psychotic depression 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Antidepressant plus antipsychotic vs placebo plus antidepressant

The review found no eligible studies for this question.

• Pharmacological treatment for psychotic depression 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found
• Pharmacological treatment for psychotic depression 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Antidepressants vs placebo

The review found no eligible studies for this question.

• Pharmacological treatment for psychotic depression 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Fluoxetine vs placebo

The review found no eligible studies for this question.

• Second‐generation antidepressants for treatment of seasonal affective disorder 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Propionyl‐L‐carnitine vs placebo

• Propionyl‐L‐carnitine for intermittent claudication 2021 · Cochrane Headline outcomes only
  no estimate extracted
  1 study · 126 participants
  Moderate

Cisapride vs placebo

The review found no eligible studies for this question.

• Interventions for preventing distal intestinal obstruction syndrome (DIOS) in cystic fibrosis 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Sclerotherapy vs placebo

The review found no eligible studies for this question.

• Treatment for telangiectasias and reticular veins 2021 · Cochrane Headline outcomes only
  no estimate extracted
  Studies not reported
  No studies found

Fludrocortisone vs placebo

• Fludrocortisone for orthostatic hypotension 2021 · Cochrane Headline outcomes only
  no estimate extracted
  0 participants
  GRADE not reported